Paxillin 抗体 (pTyr31)
Quick Overview for Paxillin 抗体 (pTyr31) (ABIN1821310)
抗原
See all Paxillin (PXN) 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
抗原表位
- pTyr31
-
特异性
- Human Paxillin when phosphorylated at Tyr31.
-
纯化方法
- Affinity purified
-
免疫原
-
Synthetic phosphopeptide corresponding to human Paxillin Tyr31 site.
Type of Immunogen: Synthetic phospho-peptide -
亚型
- IgG2a
-
-
-
-
应用备注
- Approved: ICC (8 - 25 μg/mL), WB (0.1 μg/mL)
-
说明
-
Target Species of Antibody: Human
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Sterile PBS to 0.5 mg/mL.
-
浓度
- Lot specific
-
缓冲液
- Lyophilized from PBS, trehalose
-
注意事项
- Aliquot to avoid repeated freezing and thawing.
-
储存条件
- -20 °C
-
储存方法
- Lyophilized powder may be stored at -20°C. Stable for 1 year at -20°C. Aliquot to avoid freeze-thaw cycles. Store at -20°C. Reconstituted product is stable for 1 year at -20°C.
-
-
- Paxillin (PXN)
-
别名
- PXN / Paxillin
-
背景
-
Name/Gene ID: PXN
Synonyms: PXN, Paxillin -
基因ID
- 5829
-
UniProt
- P49023
-
途径
- MAPK Pathway, EGFR Signaling Pathway, Response to Growth Hormone Stimulus, Cell-Cell Junction Organization, Maintenance of Protein Location, CXCR4-mediated Signaling Events, Signaling Events mediated by VEGFR1 and VEGFR2, Signaling of Hepatocyte Growth Factor Receptor, VEGF Signaling
抗原
-